Bioconjugation of Oligonucleotides for Treating Liver Fibrosis
Open Access
- 1 December 2007
- journal article
- research article
- Published by SAGE Publications in Oligonucleotides
- Vol. 17 (4) , 349-404
Abstract
Liver fibrosis results from chronic liver injury due to hepatitis B and C, excessive alcohol ingestion, and metal ion overload. Fibrosis culminates in cirrhosis and results in liver failure. Therefore, a potent antifibrotic therapy is urgently needed to reverse scarring and eliminate progression to cirrhosis. Although activated hepatic stellate cells (HSCs) remain the principle cell type responsible for liver fibrosis, perivascular fibroblasts of portal and central veins as well as periductular fibroblasts are other sources of fibrogenic cells. This review will critically discuss various treatment strategies for liver fibrosis, including prevention of liver injury, reduction of inflammation, inhibition of HSC activation, degradation of scar matrix, and inhibition of aberrant collagen synthesis. Oligonucleotides (ODNs) are short, single-stranded nucleic acids, which disrupt expression of target protein by binding to complementary mRNA or forming triplex with genomic DNA. Triplex forming oligonucleotides (TFOs) provide an attractive strategy for treating liver fibrosis. A series of TFOs have been developed for inhibiting the transcription of α1(I) collagen gene, which opens a new area for antifibrotic drugs. There will be in-depth discussion on the use of TFOs and how different bioconjugation strategies can be utilized for their site-specific delivery to HSCs or hepatocytes for enhanced antifibrotic activities. Various insights developed in individual strategy and the need for multipronged approaches will also be discussed.Keywords
This publication has 585 references indexed in Scilit:
- Targeting 15d-Prostaglandin J2 to Hepatic Stellate Cells: Two Options EvaluatedPharmaceutical Research, 2007
- Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environmentNucleic Acids Research, 2006
- Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMDGene Therapy, 2006
- A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populationsHepatology, 2004
- Characterization and Quantification of Triple Helix Formation in Chromosomal DNAJournal of Molecular Biology, 2004
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- The contribution of cytosine protonation to the stability of parallel DNA triple helices 1 1Edited by D. E. DraperJournal of Molecular Biology, 1998
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosisNature, 1988